Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,477 total articles
SUSS MicroTec (SESMF) shows signs of strong end-market demand despite headline margin pressure. Technicals and a sharp decline in reported short interest suggest a setup for a mid-term long trade: entry at $102.35, stop at $92.00, target at $125.00. Manage size tightly - liquidity and margin risk remain the primary hazards.
Shares of Gap have been punished in the selloff, creating an asymmetric trade: limited upside duration risk with a defined stop and a clear path to value re-rating if margins and inventory trends normalize. This is a mid-term trade idea with a strict stop and two staged targets to manage risk-reward.
Micron is trading near $1.15k with a $1.3T market cap but still shows enterprise-level profitability, strong free cash flow and customer commitments that point to continued upside. This trade targets continued HBM and data-center memory tightness over the next 180 trading days, with disciplined risk control.
Denison Mines (DNN) trades at $3.08 with a market cap near $2.79B and an active drilling calendar across high-grade Athabasca assets. The company’s enterprise value roughly equals market cap, balance-sheet liquidity looks adequate and sector-level pricing tailwinds keep upside simple to model. This is a mid-term (45 trading days) swing idea: buy fo…
Shift4 (FOUR) combines strong payment-volume growth, recurring processing revenue and meaningful free cash flow to position itself as a beneficiary of rising consumer spending on experience-driven categories. Recent insider and institutional buys, supportive technicals, and an attractive enterprise-value-to-sales profile versus growth justify a lon…
Nano Labs is a microcap fabless chip designer focused on high-throughput and vision computing. At $1.85 and a $42.7M market cap the stock is priced for disappointment, yet recent corporate moves (CEO buy, North America MoU, hardware launch) create a near-term event runway. This is a speculative, mid-term long centered on a 90-day evaluation with a …
Westgold’s edge is increasingly operational: tighter processing control, higher recoveries and stepped-up cost management can deliver outsized cashflow upside even if gold prices stay sideways. The trade here is a mid-term long that captures upside as the market re-rates operational optionality while leaving a clear stop if execution stalls.
Live Nation ($LYV) is positioned to benefit from peak summer touring and festival demand. Fundamentals show strong ticketing revenue growth, improving cash generation and an enterprise value near $41.9B; technicals are bullish and short interest remains meaningful. This trade proposes a mid-term long into the season with a defined entry, stop and t…
Dow Inc. ($DOW) is trading well below its 52-week highs after supply-chain shocks and cyclical weakness pressured top-line results. The stock looks attractive on valuation (P/S ~0.5, P/B ~1.3, EV/EBITDA ~11.5) and yields roughly 5% from the current quarterly payout, while technicals are deeply oversold. This is a mid-term swing trade: buy on weakne…
Nutex Health (NUTX) is trading with strong momentum above its short- and medium-term moving averages, backed by robust free cash flow and double-digit profitability. The stock looks actionable on a disciplined long entry after a minor pullback. This trade idea lays out an entry, stop and target with a mid-term horizon and balanced risk framing.
Helen of Troy is showing the kind of cash-generation that can neutralize past restructuring missteps and fund debt reduction. At $29.08, the stock trades at roughly 5x price-to-free-cash-flow and an EV/EBITDA under 9 — metrics that argue for a tactical long while legal and execution risks remain. Trade plan below with entry, stop and target calibra…
AtaiBeckley’s BPL-003 (mebufotenin benzoate nasal spray) has shown rapid, durable antidepressant effects in Phase 2 and the program is moving into Phase 3. With FDA Breakthrough Therapy designation, positive Phase 2b signals, and a cash runway into early 2029, the stock offers an actionable long trade for traders willing to accept biotech binary ri…
Dell’s stock has already run hard in 2026, but underneath the rally is a clear fundamental story: AI data-center buildouts are driving outsized demand for servers and storage. At roughly a $280 billion market cap, a P/E near 33 and $9.4 billion in free cash flow, Dell still trades at multiples that look reasonable versus growth and cash generation.…
Ligand Pharmaceuticals is running the playbook of a modern royalty aggregator: high-quality, cash-generative royalties, disciplined M&A, and expanding guidance after the XOMA acquisition. The stock looks attractive on a 180-trading-day horizon given accretive EPS guidance, strong free cash flow, and manageable leverage. We lay out an actionable lon…
The Manitowoc Company (MTW) is a cyclical heavy-equipment specialist trading at a market capitalization under $500M, with price-to-book near 0.74 and EV/EBITDA about 7.4. Recent operational softness has pressured earnings, but improving industry fundamentals, a healthy current ratio, bullish technicals, and concentrated short interest create a trad…
DV combines steady revenue growth, strong free cash flow, and low leverage with newly launched AI products that can expand addressable market and improve monetization. At a market cap near $1.66B and EV/EBITDA ~10.3, the stock looks attractively priced for a rebound if execution continues. I’m recommending a mid-term (45 trading days) long trade wi…
Energy Vault (NRGV) is showing improving fundamental traction - large project awards, asset-level financing and accelerating revenues - while still trading below key growth inflection multiples. I recommend a long trade with an entry at $4.72, a stop at $3.50 and a primary target of $6.50 over the next 180 trading days.
Capstone Energy+ (CGEH) has pulled back below its short- and medium-term averages despite improving visibility after an OTCQX upgrade. With a market cap near $296M and light float, a disciplined long entry around $9.10, a $12 target and $8 stop gives a defined risk/reward for a mid-term swing over the next 45 trading days.
Douglas Dynamics is a small-cap industrial play exposed to winter-weather demand and municipal contracting. Strong recent results, an accretive acquisition, and improving profitability support a tactical long. Entry at $54.00, stop $48.00, target $65.00 on a position horizon (180 trading days).
Evolv Technologies (EVLV) sells AI-based weapons-detection systems and is growing quickly but carries an internal-control investigation overhang. The stock trades near $5.90 with a market cap around $1.04B and full-year revenue guidance of $175-$180M. This trade idea recommends a long entry at $5.90, a target of $8.50 and a stop at $4.86, with a lo…
Adobe shares have been pushed lower by near-term execution concerns and AI transition questions. The fundamentals still show a cash-rich, high-return business trading at single-digit free-cash-flow multiples. This trade targets a disciplined long entry to capture mean reversion and optional upside from AI monetization, with a clear stop and time ho…
Pagaya's expanded buy-now-pay-later partnership with Upgrade, insider buying, and accelerated ABS issuance create a clear mid-term trade: enter around $18.00, stop at $15.00, target $30.00 over ~45 trading days. Fundamentals and cash flow support upside while technicals show momentum; risks include credit-cycle sensitivity and short-term overbought…
ChipMOS Technologies (IMOS) offers direct exposure to semiconductor testing and assembly — a service set that tends to re-rate when memory and foundry utilization recover. The stock is trading above its 20/50-day averages, yields ~1.1%, and carries a $2.25B market cap. This trade plan buys a measured pullback to $61.90 with a $58.00 stop and a $72.…
SES AI Corporation trades like a broken story. The stock is down sharply from its $3.73 52-week high while the company still controls differentiated Li-metal cell technology, an integrated manufacturing stack, and a balance sheet that — while stretched — keeps upside possible if execution and transparency return. This is a high-risk long trade: ent…
Dole plc (DOLE) looks attractive on a mid-term swing basis. The company benefits from resilient demand for fresh produce, recent earnings beats, and a valuation that signals limited downside at the current market cap of approximately $1.31B. We lay out an entry at $13.70, a stop at $12.50, and a target of $16.50 over a 45 trading day horizon.
